Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer

Paolo Fortina, Larry J. Kricka, David J. Graves, Jason Park, Terry Hyslop, Felicia Tam, Naomi Halas, Saul Surrey, Scott A. Waldman

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Nanotechnology has considerable promise for the detection, staging and treatment of cancer. Here, we outline one such promising application: the use of nanostructures with surface-bound ligands for the targeted delivery and ablation of colorectal cancer (CRC), the third most common malignancy and the second most common cause of cancer-related mortality in the US. Normal colonic epithelial cells as well as primary CRC and metastatic tumors all express a unique surface-bound guanylyl cyclase C (GCC), which binds the diarrheagenic bacterial heat-stable peptide enterotoxin ST. This makes GCC a potential target for metastatic tumor ablation using ST-bound nanoparticles in combination with thermal ablation with near-infrared or radiofrequency energy absorption. Furthermore, the incorporation of iron or iron oxide into such structures would provide advantages for magnetic resonance imaging (MRI). Although the scenarios outlined in this article are hypothetical, they might stimulate ideas about how other cancers could be attacked using nanotechnology.

Original languageEnglish (US)
Pages (from-to)145-152
Number of pages8
JournalTrends in Biotechnology
Volume25
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Ablation
Nanoparticles
Colorectal Neoplasms
Nanotechnology
Tumors
Neoplasms
Hot Temperature
Energy absorption
Magnetic resonance
Iron oxides
Peptides
Second Primary Neoplasms
Nanostructures
Neoplasm Staging
Therapeutics
Iron
Ligands
Infrared radiation
Imaging techniques
Epithelial Cells

ASJC Scopus subject areas

  • Bioengineering

Cite this

Fortina, P., Kricka, L. J., Graves, D. J., Park, J., Hyslop, T., Tam, F., ... Waldman, S. A. (2007). Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends in Biotechnology, 25(4), 145-152. https://doi.org/10.1016/j.tibtech.2007.02.005

Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. / Fortina, Paolo; Kricka, Larry J.; Graves, David J.; Park, Jason; Hyslop, Terry; Tam, Felicia; Halas, Naomi; Surrey, Saul; Waldman, Scott A.

In: Trends in Biotechnology, Vol. 25, No. 4, 04.2007, p. 145-152.

Research output: Contribution to journalArticle

Fortina, P, Kricka, LJ, Graves, DJ, Park, J, Hyslop, T, Tam, F, Halas, N, Surrey, S & Waldman, SA 2007, 'Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer', Trends in Biotechnology, vol. 25, no. 4, pp. 145-152. https://doi.org/10.1016/j.tibtech.2007.02.005
Fortina, Paolo ; Kricka, Larry J. ; Graves, David J. ; Park, Jason ; Hyslop, Terry ; Tam, Felicia ; Halas, Naomi ; Surrey, Saul ; Waldman, Scott A. / Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. In: Trends in Biotechnology. 2007 ; Vol. 25, No. 4. pp. 145-152.
@article{f21bd53f15514ae4939fa7925fb88206,
title = "Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer",
abstract = "Nanotechnology has considerable promise for the detection, staging and treatment of cancer. Here, we outline one such promising application: the use of nanostructures with surface-bound ligands for the targeted delivery and ablation of colorectal cancer (CRC), the third most common malignancy and the second most common cause of cancer-related mortality in the US. Normal colonic epithelial cells as well as primary CRC and metastatic tumors all express a unique surface-bound guanylyl cyclase C (GCC), which binds the diarrheagenic bacterial heat-stable peptide enterotoxin ST. This makes GCC a potential target for metastatic tumor ablation using ST-bound nanoparticles in combination with thermal ablation with near-infrared or radiofrequency energy absorption. Furthermore, the incorporation of iron or iron oxide into such structures would provide advantages for magnetic resonance imaging (MRI). Although the scenarios outlined in this article are hypothetical, they might stimulate ideas about how other cancers could be attacked using nanotechnology.",
author = "Paolo Fortina and Kricka, {Larry J.} and Graves, {David J.} and Jason Park and Terry Hyslop and Felicia Tam and Naomi Halas and Saul Surrey and Waldman, {Scott A.}",
year = "2007",
month = "4",
doi = "10.1016/j.tibtech.2007.02.005",
language = "English (US)",
volume = "25",
pages = "145--152",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer

AU - Fortina, Paolo

AU - Kricka, Larry J.

AU - Graves, David J.

AU - Park, Jason

AU - Hyslop, Terry

AU - Tam, Felicia

AU - Halas, Naomi

AU - Surrey, Saul

AU - Waldman, Scott A.

PY - 2007/4

Y1 - 2007/4

N2 - Nanotechnology has considerable promise for the detection, staging and treatment of cancer. Here, we outline one such promising application: the use of nanostructures with surface-bound ligands for the targeted delivery and ablation of colorectal cancer (CRC), the third most common malignancy and the second most common cause of cancer-related mortality in the US. Normal colonic epithelial cells as well as primary CRC and metastatic tumors all express a unique surface-bound guanylyl cyclase C (GCC), which binds the diarrheagenic bacterial heat-stable peptide enterotoxin ST. This makes GCC a potential target for metastatic tumor ablation using ST-bound nanoparticles in combination with thermal ablation with near-infrared or radiofrequency energy absorption. Furthermore, the incorporation of iron or iron oxide into such structures would provide advantages for magnetic resonance imaging (MRI). Although the scenarios outlined in this article are hypothetical, they might stimulate ideas about how other cancers could be attacked using nanotechnology.

AB - Nanotechnology has considerable promise for the detection, staging and treatment of cancer. Here, we outline one such promising application: the use of nanostructures with surface-bound ligands for the targeted delivery and ablation of colorectal cancer (CRC), the third most common malignancy and the second most common cause of cancer-related mortality in the US. Normal colonic epithelial cells as well as primary CRC and metastatic tumors all express a unique surface-bound guanylyl cyclase C (GCC), which binds the diarrheagenic bacterial heat-stable peptide enterotoxin ST. This makes GCC a potential target for metastatic tumor ablation using ST-bound nanoparticles in combination with thermal ablation with near-infrared or radiofrequency energy absorption. Furthermore, the incorporation of iron or iron oxide into such structures would provide advantages for magnetic resonance imaging (MRI). Although the scenarios outlined in this article are hypothetical, they might stimulate ideas about how other cancers could be attacked using nanotechnology.

UR - http://www.scopus.com/inward/record.url?scp=33947116241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947116241&partnerID=8YFLogxK

U2 - 10.1016/j.tibtech.2007.02.005

DO - 10.1016/j.tibtech.2007.02.005

M3 - Article

C2 - 17316852

AN - SCOPUS:33947116241

VL - 25

SP - 145

EP - 152

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 4

ER -